Relypsa (RLYP) Has Multiple Banking Relationships

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/2/2026

1. NKE
2. SPY
3. ACN
4. USO
5. NVDA
6. TRU
7. TLT
8. ON
9. WBD
10. FICO

Go back to Relypsa (RLYP) Has Multiple Banking Relationships

Wedbush Reiterates Bullish Stance on Relypsa (RLYP) Following Veltassa MoM Acceleration

April 18, 2016 11:47 AM EDT

In a note Friday, Wedbush analyst Liana Moussatos reiterated her Outperform rating and $52 price target on Relypsa, Inc. (NASDAQ: RLYP) after the third full month of Veltassa launch metrics shows month-over-month acceleration.

In March, 1,277 (+57% MoM) new patients started taking Veltassa with a free starter supply, 706 (+102% MoM) outpatient prescriptions were filled, and 201 (+14% MoM) hospital/institution units were sold.

Veltassa's early launch continues to track... More

BTIG Trims Q1 Sales Outlook on Relypsa's (RLYP) Veltassa Following Recent Update; Affirms at 'Buy'

April 15, 2016 2:44 PM EDT

BTIG affirms Relypsa, Inc. (Nasdaq: RLYP) with a Buy rating and $45 price target after the company disclosed new patient starts, outpatient prescriptions and... More

Mizuho Weighs in on Relypsa (RLYP) Veltassa Numbers and Latest on M&A

April 15, 2016 9:59 AM EDT

Mizuho Securities analyst Irina Koffler weighed in on Relypsa, Inc. (NASDAQ: RLYP) following today's Veltassa prescriptions numbers and the latest M&A speculation.

Koffler noted that Veltassa prescriptions sold were in-line with their estimates. "Relypsa released March's Veltassa numbers, and reported 1,277 patients received a free starter supply of Veltassa, 706 retail prescriptions were filled, and 201 hospital packs were sold. In all, a total of 907 prescriptions/units were reimbursed. This compares to our estimates of 1,624 patients receiving the starter kit, 700 retail TRx's... More